Helsinn Investment Fund's investment strategy centers around identifying and supporting earlystage companies that are at the forefront of innovation in the healthcare industry. The fund is specifically interested in ventures that are working on novel solutions in areas where there is a substantial gap in existing treatments or technologies—essentially, sectors where current offerings do not fully meet patient needs. This could include emerging technologies, breakthrough therapies, or novel medical devices that have the potential to make a significant impact on the quality of care.